Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data AEye, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
1.58
3.01
3.65
1.46
0.2
0.23
Cost of revenue
0.81
3.64
8.73
15.3
0.78
0.55
Gross profit
0.77
-0.63
-5.09
-13.9
-0.58
-0.32
Research and development
17.1
26.5
37.6
26.2
16.4
13.9
Selling, general and administrative
0.01
Selling and marketing
3.41
10.5
19.3
12.5
0.55
2.55
General and administrative
0
6.72
25.5
36.8
25.2
18.3
14.9
Operating expenses
27.3
62.6
93.7
73.9
35.3
31.4
Operating income
-0
-26.5
-63.2
-98.8
-87.8
-35.8
-31.7
Interest income
0
Other non-operating income
-0.07
-1.78
0.15
0.71
0.37
-2.22
Pre-tax income
-0
-2.88
-87.1
-35.5
-33.9
Income tax
0
0
0.06
0.06
-0
0.01
Net income
-0
-26.6
-65
-98.7
-87.1
-35.5
-34
EBITDA
-25.6
-62.2
-97.4
-86.2
-35.7
-31.6
EPS, basic
-7.77
-17.92
-18.82
-14.95
-4.89
-1.47
EPS, diluted
-7.77
-17.92
-18.82
-14.95
-4.89
-1.47
Shares, basic (weighted)
3.44
3.65
5.25
5.83
7.25
23.1
Shares, diluted (weighted)
3.44
3.65
5.25
5.83
7.25
23.1
Balance sheet
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.03
15.3
14.2
19.1
16.9
10.3
43.4
Short-term investments
0
150
75.1
19.6
12
43.1
Receivables
0.16
4.22
0.62
0.13
0.01
0.08
Inventory
2.66
4.09
4.55
0.58
0.18
1.02
Other current assets
0.85
0.1
0.71
0.05
0.06
0.06
Total current assets
0.03
19.5
177
106
39.8
25.2
89.6
Property, plant and equipment
4.87
5.13
7.67
0.28
0.61
0.58
Lease right-of-use assets
0
15.5
11.2
0.65
0.44
Other non-current assets
0.32
1.51
2.47
0.91
0.69
0.24
Total assets
0.03
25.9
186
133
54.3
27.1
90.9
Accounts payable
1.81
2.54
3.22
3.44
3.6
3.62
Accrued liabilities
0
3.36
8.74
9.76
6.59
Deferred revenue
0.66
2.29
0.99
0
Short-term debt
2.69
0
8.59
Total current liabilities
0
37.6
13.6
22.6
10
11.3
8.57
Long-term debt
2.88
0
Lease liabilities
0
16.7
14.9
0.48
0.24
Other non-current liabilities
0
0.79
0.13
0.41
0.06
0.6
Total liabilities
0
44.1
17.4
39.4
25.3
12
9.55
Total debt
5.58
0
0
Paid-in capital
0.02
68.5
321
346
367
388
488
Retained earnings
-0
-86.8
-152
-251
-338
-373
-407
Other comprehensive income
0
-0.39
-1.28
0.01
0.01
0.03
Shareholders' equity
5.71
-18.2
169
94
29
15.1
81.3
Total equity
5.71
-18.2
169
94
29
15.1
81.3
Total liabilities and equity
0.03
25.9
186
133
54.3
27.1
90.9
Shares outstanding
3.39
5.19
5.44
6.31
13.7
45.2
Cash flow statement
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0
-26.6
-65
-98.7
-87.1
-35.5
-34
Depreciation and amortization
0.92
1.01
1.42
1.55
0.13
0.16
Stock-based compensation
1.95
10
24
18.1
9.05
5.52
Change in receivables
-0.01
-4.07
3.61
0.45
0.09
-0.07
Change in inventory
-0.31
-2.63
-2.63
-2.46
0.25
-0.68
Change in payables
0.48
0.56
0.84
0.25
0.16
0.01
Cash from operations
-19.7
-55.7
-71.6
-50.7
-26.6
-27.8
Capital expenditures
-4.04
-1.02
-4.2
-1.95
-0.49
-0.11
Purchases of investments
0
-151
-23.9
-19.3
-24.2
-53.8
Cash from investing
-4.04
-152
68.5
55.4
7.74
-30.8
Debt issued
2.27
10
0
Debt repaid
-0.67
-13.3
Stock issued
0.03
0.66
0
2.89
0.14
11.1
91
Cash from financing
0.03
32
207
8.07
-6.76
10.1
91.7
Net change in cash
0.03
8.29
-0.17
4.88
-2.13
-8.82
33.1
Free cash flow
-23.7
-56.7
-75.8
-52.7
-27.1
-27.9
Interest paid
0.2
0.36
0.13
0.12
0
0
Income taxes paid
0
0.02
0.02
-0
0.06
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.21 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-103.1%
Gross profit / revenue.
Operating margin
-8,002.0%
Operating income / revenue.
EBITDA margin
-7,963.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-7,786.0%
Net income / revenue.
FCF margin
-6,639.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-6,547.0%
Cash from operations / revenue.
Return on equity (ROE)
-51.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-45.8%
Net income / average total assets.
Return on invested capital (ROIC)
-49.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
3,397.0%
Research and development expense / revenue.
Stock-based pay / revenue
1,294.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
92.0%
Capital expenditures / revenue.
D&A / revenue
38.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
15.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-60.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-31.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
437.8%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-4.7%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
235.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-12.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
28.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
218.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
64.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
46.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
10.8x
Current assets / current liabilities.
Quick ratio
10.4x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
10.4x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.76
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.01
Revenue / diluted weighted shares.
FCF per share
-$0.65
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.64
Cash from operations / diluted weighted shares.
Book value per share
$1.47
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
125x
Market cap / revenue.
P/B
0.82x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.82x
Market cap / tangible book value, when positive.
FCF yield
-53.1%
Free cash flow / market cap.
Earnings yield
-62.3%
Net income / market cap (the inverse of P/E).
What was AEye, Inc.'s revenue in fiscal 2025?
AEye, Inc. reported revenue of $233.0K for fiscal 2025, 15.3% higher than the year before.
Was AEye, Inc. profitable in fiscal 2025?
No. It reported a net loss of $34.0M.
How much free cash flow did AEye, Inc. generate in fiscal 2025?
Cash from operations of $27.8M minus capital expenditures of $109.0K left free cash flow of -$27.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.